NCT05950724View on ClinicalTrials.gov

RENAL: TNF-alpha Inhibitor for Improving Renal Dysfunction and Primary Graft Dysfunction After Lung Transplant

EARLY_PHASE1Enrolling by invitationINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

September 17, 2023

Primary Completion Date

April 30, 2024

Study Completion Date

April 30, 2025

Conditions

Lung Transplant; Complications

Interventions

DRUG

Etanercept Injection [Enbrel]

25 mg subcutaneous injection

Trial Locations (1)

60611

Northwestern University, Chicago

All Listed Sponsors

lead

Northwestern University

OTHER